Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
$1.13 billion in third quarter global product net sales On track to submit seronegative gMG sBLA by year-end and report ADAPT-OCULUS results in 1H26 – supporting pursuit of broadest MG label of any...
-
Regulated information Revenue of €445 million, 3.8% lower LFL year on year due to softer market demand, and 3.7% up versus Q2 on volume growth driven by contract gains;Adj. EBITDA margin at 11.4%,...
-
ING posts 3Q2025 net result of €1,787 million, with strong growth in fee income and customer lending
ING posts 3Q2025 net result of €1,787 million, with strong growth in fee income and customer lending Profit before tax increases quarter-on-quarter to €2,560 million; CET1 ratio rises to 13.4% ...
-
VYVGART demonstrated clinically meaningful benefit across all AChR-Ab seronegative gMG subtypes in ADAPT SERON, supporting broad role of pathogenic IgGs in disease activityFinal ADAPT SC+ results...
-
ING to appoint Ida Lerner as chief financial officer ING announced today that Ida Lerner will be appointed chief financial officer of ING. Until recently, Ida served as chief financial officer at...
-
Information réglementée Déclaration intermédiaire par le Conseil d'administrationYpres, Belgique - le 29 octobre 2025, 07.00 H. CET Veuillez trouver ici le lien vers notre dernier...
-
Gereglementeerde informatie Tussentijdse verklaring, opgesteld door de Raad van BestuurIeper, België - 29 oktober 2025, 07.00 uur CET Geachte, hieronder vindt u de link naar ons meest...
-
Regulated information Intermediate declaration by the Board of Directors Ieper, Belgium - October 29th, 2025, 07.00 hrs CET Dear, Please find herewith the link to our most recent press...
-
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL....
-
Please find below Aedifica’s interim financial report for the 3rd quarter of the 2025 financial year. Progress on Aedifica’s exchange offer on all Cofinimmo shares Aedifica has formally filed its...